FI963083L - Normotensiivisen glaukooman hoito angiotensiini-II-antagonisteilla - Google Patents

Normotensiivisen glaukooman hoito angiotensiini-II-antagonisteilla Download PDF

Info

Publication number
FI963083L
FI963083L FI963083A FI963083A FI963083L FI 963083 L FI963083 L FI 963083L FI 963083 A FI963083 A FI 963083A FI 963083 A FI963083 A FI 963083A FI 963083 L FI963083 L FI 963083L
Authority
FI
Finland
Prior art keywords
angiotensin
antagonists
treatment
normotensive glaucoma
normotensive
Prior art date
Application number
FI963083A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963083A0 (fi
FI963083A7 (fi
Inventor
Alica Huxley
Georg Mathis
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI963083A0 publication Critical patent/FI963083A0/fi
Publication of FI963083A7 publication Critical patent/FI963083A7/fi
Publication of FI963083L publication Critical patent/FI963083L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI963083A 1994-02-08 1995-01-26 Normotensiivisen glaukooman hoito angiotensiini-II-antagonisteilla FI963083L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94810071 1994-02-08
PCT/IB1995/000056 WO1995021609A1 (fr) 1994-02-08 1995-01-26 Antagonistes de l'angiotensine ii destines au traitement du glaucome normotensif

Publications (3)

Publication Number Publication Date
FI963083A0 FI963083A0 (fi) 1996-08-05
FI963083A7 FI963083A7 (fi) 1996-08-07
FI963083L true FI963083L (fi) 1996-08-07

Family

ID=8218203

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963083A FI963083L (fi) 1994-02-08 1995-01-26 Normotensiivisen glaukooman hoito angiotensiini-II-antagonisteilla

Country Status (17)

Country Link
US (1) US5889020A (fr)
EP (1) EP0743852B1 (fr)
JP (1) JPH09508641A (fr)
CN (1) CN1140409A (fr)
AT (1) ATE300287T1 (fr)
AU (1) AU1423795A (fr)
CA (1) CA2181461A1 (fr)
CY (1) CY2567B1 (fr)
DE (1) DE69534339T2 (fr)
DK (1) DK0743852T3 (fr)
ES (1) ES2243933T3 (fr)
FI (1) FI963083L (fr)
IL (1) IL112520A0 (fr)
MX (1) MX9603259A (fr)
NO (1) NO963064D0 (fr)
WO (1) WO1995021609A1 (fr)
ZA (1) ZA95958B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2125251C (fr) * 1993-06-07 2005-04-26 Yoshiyuki Inada Composition pharmaceutique pour le traitement des affections mediees par l'angiotensine ii
CZ284395B6 (cs) * 1994-03-16 1998-11-11 Sankyo Company Limited Prostředek pro snižování očního tlaku
JPH10167961A (ja) * 1996-12-11 1998-06-23 Santen Pharmaceut Co Ltd 緑内障治療剤
TR200100062T2 (tr) * 1998-07-10 2001-06-21 Novartis Ag Valsartan ve kalsiyum kanalı bloklayıcısının anti-hipertensif kombinasyonu
US6204281B1 (en) 1998-07-10 2001-03-20 Novartis Ag Method of treatment and pharmaceutical composition
ATE289204T1 (de) * 1999-04-28 2005-03-15 Takeda Pharmaceutical Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie
ATE295721T1 (de) * 1999-06-11 2005-06-15 Sankyo Co Den augendruck senkende zusammensetzung zur topischen anwendung
US6395728B2 (en) 1999-07-08 2002-05-28 Novartis Ag Method of treatment and pharmaceutical composition
AU7954900A (en) * 1999-10-25 2001-05-08 Senju Pharmaceutical Co., Ltd. Tension-relieving agents for ciliary muscle
TWI290470B (en) * 1999-12-01 2007-12-01 Sankyo Co The composition for treating glaucoma
WO2001060362A1 (fr) * 2000-02-18 2001-08-23 Takeda Chemical Industries, Ltd. INHIBITEURS DE TNF-$g(a)
AU2002218527A1 (en) * 2000-12-05 2002-06-18 Sankyo Company Limited Ocular tension-lowering compositions for topical administration
EG24716A (en) * 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
KR101087519B1 (ko) * 2003-04-15 2011-11-28 상꾜 가부시키가이샤 안구 내 혈관 신생성 질환의 예방 또는 치료를 위한 의약
DE602005025755D1 (de) 2004-06-04 2011-02-17 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
US20060160871A1 (en) * 2004-12-07 2006-07-20 Nektar Therapeutics Stable non-crystalline formulation comprising losartan
PL1872783T3 (pl) * 2005-04-21 2012-05-31 Santen Pharmaceutical Co Ltd Środek leczniczy w schorzeniach rogówkowo-spojówkowych
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
HRP20151440T1 (hr) * 2008-12-29 2016-01-29 Trevena, Inc. Efektori beta-arestina i sastavi i metode u kojima se koriste
RU2443416C2 (ru) * 2010-05-17 2012-02-27 Республиканское Унитарное производственное предприятие "Белмедпрепараты" Капли глазные
US9518086B2 (en) 2014-02-07 2016-12-13 Trevena, Inc. Crystalline and amorphous forms of a β-arrestin effector
US9611293B2 (en) 2014-05-19 2017-04-04 Trevena, Inc. Synthesis of beta-arrestin effectors
CN105188250A (zh) * 2015-09-09 2015-12-23 上海联影医疗科技有限公司 靶组件以及具有该靶组件的直线加速器
CN105244434B (zh) * 2015-10-13 2017-10-10 北京科技大学 一种C掺杂ZnO热电材料的制备方法
WO2018002673A1 (fr) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Nouvelles formulations d'antagonistes du récepteur de l'angiotensine ii

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03223281A (ja) * 1989-12-01 1991-10-02 Glaxo Group Ltd ベンゾチオフェン誘導体
GB9027211D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
IL104755A0 (en) * 1992-02-17 1993-06-10 Ciba Geigy Ag Treatment of glaucoma

Also Published As

Publication number Publication date
EP0743852B1 (fr) 2005-07-27
DE69534339T2 (de) 2006-05-24
DE69534339D1 (de) 2005-09-01
AU1423795A (en) 1995-08-29
US5889020A (en) 1999-03-30
DK0743852T3 (da) 2005-10-17
JPH09508641A (ja) 1997-09-02
ES2243933T3 (es) 2005-12-01
NO963064L (no) 1996-07-23
NO963064D0 (no) 1996-07-23
FI963083A0 (fi) 1996-08-05
WO1995021609A1 (fr) 1995-08-17
ATE300287T1 (de) 2005-08-15
FI963083A7 (fi) 1996-08-07
IL112520A0 (en) 1995-05-26
MX9603259A (es) 1997-03-29
ZA95958B (en) 1995-08-08
EP0743852A1 (fr) 1996-11-27
CA2181461A1 (fr) 1995-08-17
CN1140409A (zh) 1997-01-15
CY2567B1 (en) 2008-07-02

Similar Documents

Publication Publication Date Title
FI963083A7 (fi) Normotensiivisen glaukooman hoito angiotensiini-II-antagonisteilla
EP0934305A4 (fr) Antagonistes de l'integrine
NO992806D0 (no) Terapeutiske midler
DK0738150T3 (da) Bicykliske fibrinogene antagonister
EP0946164A4 (fr) Antagonistes de l'integrine
FI932518A7 (fi) Angiotensiinin II antagonistit
FR2725204B1 (fr) 2-hydroxyphenyltriazines comme agents photostabilisants
FI972681L (fi) Kynsien sientenvastainen käsittely
DE69535321D1 (de) Wegwerfbadeanzug
DE69534213D1 (de) Therapeutisch wirksame Heterocyclen
FI932517A7 (fi) Angiotensiinin II antagonistit
DE69726189D1 (de) Mikrokeratom
DE59408418D1 (de) Selbstfahrender Mähdrescher
ID18679A (id) Penggunaan terapi lanjutan
EP0996433A4 (fr) Procedes de traitement d'etats associes au lactosylceramide
DE69807225D1 (de) Vliesstoffbehandlung
FI962499L (fi) Herbisidien tehon parantaminen
BR9507537A (pt) Heterociclilbenzonitrilas
DE69520835D1 (de) Topfschliefscheibe und entsprechendes verschleissteil
ATA137796A (de) Faserbehandlungsmittel
FI990032L (fi) Okulaarisia hypotensiivisiä aktiivisia yhdisteitä
DE69709755D1 (de) Den oberteil von flaschen untergreifender träger
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
KR970050970U (ko) 아이샤워
SE9602970D0 (sv) Behandlingsspruta

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed